Drugs + Money

Mexico’s Lawsuit Against US Gunmakers Reaches Supreme Court

Do gun manufacturers in the United States bear responsibility for thousands of murders by drug trafficking organizations in Mexico? The…

February 27, 2025

“It’s Very Real”—Harm Reduction Research Facing DOGE Funding Cuts

As Elon Musk and his Department of Government Efficiency (DOGE) take a chainsaw to federal agencies and funding, critical research—including that related…

February 25, 2025

Utah Sues Pharmacy Benefit Managers for “Central Role” in Opioid OD Crisis

Utah is suing two of the nation’s top pharmacy benefit managers (PBM), the companies that shape prescription drug pricing, alleging…

January 2, 2025

Baltimore’s $5.2 Billion Opioid Lawsuit Now in the Hands of One Judge

A Baltimore judge will soon decide the fate of a landmark opioid lawsuit. The beleaguered city hopes to obtain billions…

December 17, 2024

CBP Rolls Out Mildly Surprising Workforce Naloxone Policy

Customs and Border Protection (CBP) has implemented its first internal policy covering staff access to naloxone. While it revolves entirely…

November 7, 2024

Record High for Banks, Credit Unions Involved in Cannabis Industry

A record number of banks are now reporting that they’re working with state-legal marijuana businesses amid increased pressure on Congress…

October 28, 2024

FDA Reports Largest-Ever Seizure of Unregulated Nicotine Vapes

On October 22, the Food and Drug Administration announced what appears to be the United States government's largest seizure of…

October 24, 2024

A Death Row Pastor’s View of Executions

From 2010 to 2015 I was incarcerated at Riverbend Maximum Security Institution in Nashville, Tennessee, the site of death row…

October 21, 2024

License Fees a Sticking Point as Colorado Plans Legal Psilocybin Services

The clock is ticking for legal psilocybin therapy to begin in Colorado. In 2022, voters approved Proposition 122, a measure…

October 3, 2024

DEA Raises ADHD Med Production Quotas. It Could Just Fix the Shortage.

The Drug Enforcement Administration is allowing pharmaceutical companies to produce a higher volume of Vyvanse and its generic versions. The…

September 10, 2024